People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Thiogenesis Therapeutics, Corp. | — | Pharma | Pre-Seed | $849K | $302K | 2022 |
Brook Riggins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brook Riggins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrice G. Rioux | 1 | 1 |
| W. Hogan G. Mullally | 1 | 1 |
| Brook G. Riggins | 1 | 1 |
| Christopher G. Starr | 1 | 1 |
| Kim G. Tsuchimoto | 1 | 1 |
| Hogan W. Mullally | 1 | 1 |
| Kim W. Tsuchimoto | 1 | 1 |
| Patrice Rioux | 1 | 1 |
| Christopher W. Starr | 1 | 1 |
| Neil A. Johnson | 1 | 1 |
| W. Hogan A. Mullally | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.